01453nam a2200349 c 4500001001300000005001500013007000300028008004100031020003400072049002800106052001700134056001400151082001500165245014600180260004200326300004700368500014400415504002400559650004500583650004700628700004900675700003600724700005600760700005600816880006100872880004800933880002600981880002701007880002701034880003101061950001101092KMO20223299220220808104425ta220623s2022    ulkad         000   kor    a9788991232860g03510:c\270000 lEM8286887lEM8286888c201a518.44b22-7  a518.442601a615.19223006880-01a대한민국 신약개발 성공전략 :b신약개발 프로세스의 이해 /d최유나,e이형기,e홍예솔,e원정현 지음  6880-02a서울 :b청년의사,c2022  a376 p. :b천연색삽화, 도표 ;c23 cm  a권말부록: 1. 의약품 정책의 중심은 제품이 아니라 환자다 ;  2. 신약개발이라는 단어 앞에 K자를 붙이려면  a참고문헌 수록 8a신약(의약품)[新藥]0KSH2004043562 8a신약 개발[新藥開發]0KSH19980382301 6880-03a최유나,d1982-0KAC2022130734aut1 6880-04a이형기0KAC2018355081 6880-05a홍예솔,g洪藝率,d1986-0KAC2022130901 6880-06a원정현,g元禎晛,d1997-0KAC202213092006245-01/(BaDaehanminguk sinyak gaebal seonggong jeollyak  6260-02/(BaSeoul :bCheongnyeon Uisa,c20221 6700-03/(BaChoe, Yuna1 6700-04/(BaI, Hyeonggi1 6700-05/(BaHong, Yesol1 6700-06/(BaWon, Jeonghyeon0 b\27000